Skip banner
HomeSourcesHow Do I?OverviewHelp
Return To Search FormFOCUS
Search Terms: patent, extension, drug

Document ListExpanded ListKWICFULL format currently displayed

Previous Document Document 23 of 195. Next Document

Copyright 2000 The Washington Post  
The Washington Post

November 1, 2000, Wednesday, Final Edition

SECTION: EDITORIAL; Pg. A32

LENGTH: 354 words

HEADLINE: Rep. Moran's Loan Deal

BODY:


REP. JIM MORAN was wrong to accept an unsecured, open-ended $ 25,000 loan from Schering-Plough Corp. lobbyist Terry Lierman and--only days later--enlist as a cosponsor of a bill to help that company preserve its monopoly on an allergy drug. Even if you accept the explanations of the two men that the deal was based solely on their longstanding personal friendship, it was inappropriate. Their direct professional relationship should have given Rep. Moran more than a little pause; the possible legal improprieties require an official investigation. Mr. Moran is running for reelection in Virginia. Mr. Lierman is running against Rep. Connie Morella in Maryland.

Mr. Moran insists that his support of Schering-Plough's efforts to get a patent extension for its profitable drug Claritin had nothing to do with the loan. He said he was convinced by the company's argument that it deserved the extension because the drug's entry into the market had been delayed. The company had tried for years and failed to get an extension just for Claritin, and its big-time lobbying team had begun pushing instead for a patent review board--a device that would have invited a constant stream of such cases.

Mr. Moran needed money at the time and got the loan at 8 percent annual interest; the minimum rate for an unsecured personal loan in the Washington area was then 12.5 percent. House members are told to contact the ethics committee before entering into such loan arrangements; and not to accept gifts valued at more than $ 250 unless the committee issues a written determination. Mr. Moran contacted the committee three days after getting the loan; and, rather than state that it was coming from a lobbyist, he said only that it was from an individual, and he wondered if there was any "limitation on the profession of the creditor."

Why so late and so vague? Members of Congress are prohibited from soliciting a gift from anyone with interests before the House. Was there any soliciting in this instance? These and other questions as to the conduct of both men beg for better answers than have yet been given.





LOAD-DATE: November 01, 2000




Previous Document Document 23 of 195. Next Document


FOCUS

Search Terms: patent, extension, drug
To narrow your search, please enter a word or phrase:
   
About LEXIS-NEXIS® Academic Universe Terms and Conditions Top of Page
Copyright © 2001, LEXIS-NEXIS®, a division of Reed Elsevier Inc. All Rights Reserved.